Arlinda Lee
Stock Analyst at Canaccord Genuity
(1.38)
# 3,520
Out of 5,182 analysts
41
Total ratings
36.59%
Success rate
-0.24%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Arlinda Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DCTH Delcath Systems | Maintains: Buy | $18 → $21 | $9.63 | +118.07% | 3 | Sep 7, 2023 | |
| XFOR X4 Pharmaceuticals | Maintains: Buy | $600 → $300 | $4.24 | +6,975.47% | 3 | Apr 5, 2022 | |
| NKTR Nektar Therapeutics | Maintains: Buy | $375 → $90 | $76.99 | +16.90% | 5 | Mar 16, 2022 | |
| RYTM Rhythm Pharmaceuticals | Maintains: Buy | $45 → $36 | $86.29 | -58.28% | 3 | Mar 7, 2022 | |
| CELC Celcuity | Initiates: Buy | $50 | $112.63 | -55.61% | 1 | Oct 8, 2021 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $151 → $160 | $49.51 | +223.17% | 3 | Aug 16, 2021 | |
| BCYC Bicycle Therapeutics | Maintains: Buy | $36 → $40 | $5.05 | +692.08% | 3 | Jul 15, 2021 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $92 → $105 | $22.45 | +367.71% | 12 | Oct 29, 2020 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $23 → $27 | $64.49 | -58.13% | 3 | May 19, 2020 | |
| BDTX Black Diamond Therapeutics | Initiates: Buy | $50 | $2.39 | +1,992.05% | 1 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $5.89 | +4,484.04% | 3 | Nov 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $160 | $4.47 | +3,479.42% | 1 | Mar 29, 2018 |
Delcath Systems
Sep 7, 2023
Maintains: Buy
Price Target: $18 → $21
Current: $9.63
Upside: +118.07%
X4 Pharmaceuticals
Apr 5, 2022
Maintains: Buy
Price Target: $600 → $300
Current: $4.24
Upside: +6,975.47%
Nektar Therapeutics
Mar 16, 2022
Maintains: Buy
Price Target: $375 → $90
Current: $76.99
Upside: +16.90%
Rhythm Pharmaceuticals
Mar 7, 2022
Maintains: Buy
Price Target: $45 → $36
Current: $86.29
Upside: -58.28%
Celcuity
Oct 8, 2021
Initiates: Buy
Price Target: $50
Current: $112.63
Upside: -55.61%
CRISPR Therapeutics AG
Aug 16, 2021
Maintains: Buy
Price Target: $151 → $160
Current: $49.51
Upside: +223.17%
Bicycle Therapeutics
Jul 15, 2021
Maintains: Buy
Price Target: $36 → $40
Current: $5.05
Upside: +692.08%
Ultragenyx Pharmaceutical
Oct 29, 2020
Maintains: Buy
Price Target: $92 → $105
Current: $22.45
Upside: +367.71%
Halozyme Therapeutics
May 19, 2020
Maintains: Buy
Price Target: $23 → $27
Current: $64.49
Upside: -58.13%
Black Diamond Therapeutics
Feb 24, 2020
Initiates: Buy
Price Target: $50
Current: $2.39
Upside: +1,992.05%
Nov 5, 2019
Maintains: Buy
Price Target: $225 → $270
Current: $5.89
Upside: +4,484.04%
Mar 29, 2018
Maintains: Buy
Price Target: $300 → $160
Current: $4.47
Upside: +3,479.42%